여성형 유방 수술 시장 : 규모, 점유율, 성장, 산업 분석, 지역 인사이트 및 예측(2026-2034년)

Growth Factors of gynecomastia procedures Market

The global gynecomastia procedures market was valued at USD 481.8 million in 2025 and is projected to grow from USD 507.8 million in 2026 to USD 812.3 million by 2034, registering a CAGR of 6.0% during the forecast period. Gynecomastia procedures are performed to reduce enlarged male breast tissue and create a flatter, more masculine chest contour. These treatments generally include liposuction, gland excision, or a combination of both, depending on whether the enlargement is caused by excess fat, glandular tissue, or mixed tissue.

The market is growing due to increasing awareness of male aesthetic procedures, rising focus on physical appearance, and growing treatment demand among men seeking better comfort, confidence, and mental well-being. In addition, obesity, hormonal imbalance, medication-related breast enlargement, and wider acceptance of cosmetic surgery among men are supporting market expansion. North America dominated the global market in 2025 with a 35.82% market share.

Gynecomastia Procedures Market Trends

A major trend in the market is the growing adoption of liposuction-led treatment approaches. Many clinics now use liposuction as a primary method, especially when gynecomastia is linked to excess fatty tissue. Liposuction offers smaller scars, improved chest contouring, shorter recovery, and the option to combine with gland excision when required. This trend aligns with the broader demand for minimally invasive cosmetic procedures.

In January 2024, Apyx published safety data on Renuvion used after liposuction, while in February 2024 it promoted educational programs related to body contouring and liposuction applications.

Market Drivers

The rising prevalence of obesity and lifestyle-related hormonal imbalance is a key factor accelerating market growth. Higher body fat levels can increase estrogen activity in men, which may contribute to enlarged breast tissue. Poor diet, lack of exercise, alcohol consumption, and some medications are also linked to gynecomastia development. As awareness improves, more men are seeking medical consultation instead of ignoring the condition, especially in urban areas where aesthetic awareness and lifestyle-related health concerns are higher.

Market Restraints

High out-of-pocket treatment cost remains a major restraint. Gynecomastia procedures are often considered elective or cosmetic, so insurance coverage is limited in many markets. Patients must usually pay for surgeon fees, anesthesia, facility charges, post-operative care, and recovery-related expenses. These costs may delay treatment decisions, particularly in price-sensitive regions and among patients who view the procedure as non-essential.

Market Opportunities

The expansion of minimally invasive body contouring services is creating strong growth opportunities. Providers are increasingly promoting faster recovery, shorter downtime, awake procedures, and improved skin tightening technologies. These benefits make gynecomastia treatment more attractive to working-age men. For example, AirSculpt expanded its body contouring centers in 2024 across Columbus, Deerfield, Birmingham, and White Plains, supporting demand for minimally invasive fat removal and body shaping services.

Market Challenges

Stigma and delayed decision-making remain important market challenges. Many men avoid consultation due to embarrassment or the belief that the condition may improve naturally. Unlike some other cosmetic treatments, gynecomastia procedures often involve a long decision cycle, as patients may hide the condition for years before seeking treatment. Proper diagnosis is also important, as gynecomastia may involve fat, gland tissue, or both, requiring realistic counseling and personalized treatment planning.

Segment Analysis

By procedure type, the market is segmented into liposuction procedures, excision procedures, and others. The liposuction procedures segment is expected to hold the largest market share, as many cases involve excess fatty tissue. Liposuction supports smaller entry points, faster recovery, and better contouring results. The excision procedures segment is projected to grow at a CAGR of 5.6% during the forecast period.

By age group, the market is divided into 18-40 years and above 40 years. The 18-40 years segment dominated the market in 2025 due to stronger emphasis on appearance, fitness, body confidence, and social comfort. The above 40 years segment is expected to grow at a CAGR of 5.7%.

By indication, the market includes physiological gynecomastia, drug-induced gynecomastia, and others. Physiological gynecomastia dominated in 2025, as most cases are linked to natural hormone changes, obesity, puberty history, aging, or metabolic factors. The drug-induced gynecomastia segment is projected to grow at a CAGR of 5.6%.

By service provider, the market is divided into hospitals & ASCs, specialty cosmetic surgery clinics, and others. Specialty cosmetic surgery clinics held the highest market share in 2025 and are expected to account for 54.9% share in 2026, driven by strong expertise in male chest contouring and aesthetic procedures.

Regional Analysis

North America led the global market with USD 172.6 million in 2025, compared to USD 164.4 million in 2024. The region's growth is supported by high awareness of male aesthetics, rising obesity prevalence, and strong adoption of cosmetic procedures. The U.S. market is estimated at USD 155.9 million in 2026, representing around 30.7% of global sales.

Europe is projected to reach USD 154.2 million in 2026, growing at a CAGR of 5.5%. The U.K. market is estimated at USD 25.9 million in 2026, while Germany is expected to reach USD 35.6 million.

Asia Pacific is projected to reach USD 135.8 million in 2026, supported by growing medical aesthetics demand in China, India, and Japan. China is estimated at USD 45.5 million, India at USD 30.5 million, and Japan at USD 23.9 million in 2026.

Latin America is expected to reach USD 22.1 million in 2026, while the GCC market is projected at USD 5.4 million. South Africa is estimated at USD 2.2 million in 2026.

Competitive Landscape

The global market is semi-consolidated, with key players including The Plastic Surgery Clinic, Transform Hospital Group, Spire Healthcare Group plc, Nuffield Health, Apollo Cosmetic Clinics, Fortis Healthcare, VLCC Health Care Ltd., Kaya Limited, Bangkok Hospital Group, and Bumrungrad International Hospital. These providers are focusing on clinic expansion, advanced body contouring technologies, collaborations, and specialized male aesthetic services.

Key Industry Developments

In March 2026, Signature Clinic launched LipoForme, a dedicated U.K. clinic chain for liposuction and body contouring. In June 2024, BioZen updated its drug development program for gynecomastia treatment. In March 2024, Cleveland Clinic Abu Dhabi introduced an improved reconstructive procedure for gynecomastia outcomes. In June 2023, researchers associated with the American Society of Plastic Surgeons introduced a new affordable gynecomastia treatment.

Conclusion

The gynecomastia procedures market is expected to grow steadily from USD 481.8 million in 2025 to USD 507.8 million in 2026, reaching USD 812.3 million by 2034. Growth will be driven by rising obesity, hormonal imbalance, male aesthetic awareness, and demand for minimally invasive body contouring. Although high treatment costs and social stigma remain barriers, expanding specialty clinics and advanced liposuction-based procedures are expected to support strong market growth through 2034.

Segmentation By Procedure Type, Age Group, Indication, Service Provider, and Region

By Procedure Type * Liposuction Procedures

• Excision Procedures
• Others

By Age Group * 18-40 Years

• Above 40 Years

By Indication * Physiological Gynecomastia

• Drug-Induced Gynecomastia
• Others

By Service Provider * Hospitals & ASCs

• Specialty Cosmetic Surgery Clinics
• Others

By Region * North America (By Procedure Type, Age Group, Indication, Service Provider, and Country)

• U.S.
• Procedure Type
  • Canada
• Procedure Type
• Europe (By Procedure Type, Age Group, Indication, Service Provider, and Country/Sub-region)
  • Germany
• Procedure Type
  • U.K.
• Procedure Type
  • France
• Procedure Type
  • Spain
• Procedure Type
  • Italy
• Procedure Type
  • Scandinavia
• Procedure Type
  • Rest of Europe
• Procedure Type
• Asia Pacific (By Procedure Type, Age Group, Indication, Service Provider, and Country/Sub-region)
  • China
• Procedure Type
  • Japan
• Procedure Type
  • India
• Procedure Type
  • Australia
• Procedure Type
  • Southeast Asia
• Procedure Type
  • Rest of Asia Pacific
• Procedure Type
• Latin America (By Procedure Type, Age Group, Indication, Service Provider, and Country/Sub-region)
  • Brazil
• Procedure Type
  • Mexico
• Procedure Type
  • Rest of Latin America
• Procedure Type
• Middle East & Africa (By Procedure Type, Age Group, Indication, Service Provider, and Country/Sub-region)
  • GCC
• Procedure Type
  • South Africa
• Procedure Type
  • Rest of the Middle East & Africa
• Procedure Type

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Gynecomastia Procedures, Key Countries
• 4.2. Pricing Analysis, Key Countries
• 4.3. Technological Advancements in Gynecomastia Procedures
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Gynecomastia Procedures Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Procedure Type
  • 5.1.1. Liposuction Procedures
  • 5.1.2. Excision Procedures
  • 5.1.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Age Group
  • 5.2.1. 18-40 Years
  • 5.2.2. Above 40 Years
• 5.3. Market Analysis, Insights and Forecast - By Indication
  • 5.3.1. Physiological Gynecomastia
  • 5.3.2. Drug-Induced Gynecomastia
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Service Provider
  • 5.4.1. Hospitals & ASCs
  • 5.4.2. Specialty Cosmetic Surgery Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East and Africa

6. North America Gynecomastia Procedures Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Procedure Type
  • 6.1.1. Liposuction Procedures
  • 6.1.2. Excision Procedures
  • 6.1.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Age Group
  • 6.2.1. 18-40 Years
  • 6.2.2. Above 40 Years
• 6.3. Market Analysis, Insights and Forecast - By Indication
  • 6.3.1. Physiological Gynecomastia
  • 6.3.2. Drug-Induced Gynecomastia
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Service Provider
  • 6.4.1. Hospitals & ASCs
  • 6.4.2. Specialty Cosmetic Surgery Clinics
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Procedure Type
  • 6.5.2. Canada
    • 6.5.2.1. By Procedure Type

7. Europe Gynecomastia Procedures Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Procedure Type
  • 7.1.1. Liposuction Procedures
  • 7.1.2. Excision Procedures
  • 7.1.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Age Group
  • 7.2.1. 18-40 Years
  • 7.2.2. Above 40 Years
• 7.3. Market Analysis, Insights and Forecast - By Indication
  • 7.3.1. Physiological Gynecomastia
  • 7.3.2. Drug-Induced Gynecomastia
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Service Provider
  • 7.4.1. Hospitals & ASCs
  • 7.4.2. Specialty Cosmetic Surgery Clinics
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Procedure Type
  • 7.5.2. Germany
    • 7.5.2.1. By Procedure Type
  • 7.5.3. France
    • 7.5.3.1. By Procedure Type
  • 7.5.4. Spain
    • 7.5.4.1. By Procedure Type
  • 7.5.5. Italy
    • 7.5.5.1. By Procedure Type
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Procedure Type
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Procedure Type

8. Asia Pacific Gynecomastia Procedures Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Procedure Type
  • 8.1.1. Liposuction Procedures
  • 8.1.2. Excision Procedures
  • 8.1.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Age Group
  • 8.2.1. 18-40 Years
  • 8.2.2. Above 40 Years
• 8.3. Market Analysis, Insights and Forecast - By Indication
  • 8.3.1. Physiological Gynecomastia
  • 8.3.2. Drug-Induced Gynecomastia
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Service Provider
  • 8.4.1. Hospitals & ASCs
  • 8.4.2. Specialty Cosmetic Surgery Clinics
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Procedure Type
  • 8.5.2. Australia
    • 8.5.2.1. By Procedure Type
  • 8.5.3. China
    • 8.5.3.1. By Procedure Type
  • 8.5.4. India
    • 8.5.4.1. By Procedure Type
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Procedure Type
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Procedure Type

9. Latin America Gynecomastia Procedures Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Procedure Type
  • 9.1.1. Liposuction Procedures
  • 9.1.2. Excision Procedures
  • 9.1.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Age Group
  • 9.2.1. 18-40 Years
  • 9.2.2. Above 40 Years
• 9.3. Market Analysis, Insights and Forecast - By Indication
  • 9.3.1. Physiological Gynecomastia
  • 9.3.2. Drug-Induced Gynecomastia
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Service Provider
  • 9.4.1. Hospitals & ASCs
  • 9.4.2. Specialty Cosmetic Surgery Clinics
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Procedure Type
  • 9.5.2. Mexico
    • 9.5.2.1. By Procedure Type
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Procedure Type

10. Middle East and Africa Gynecomastia Procedures Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Procedure Type
  • 10.1.1. Liposuction Procedures
  • 10.1.2. Excision Procedures
  • 10.1.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Age Group
  • 10.2.1. 18-40 Years
  • 10.2.2. Above 40 Years
• 10.3. Market Analysis, Insights and Forecast - By Indication
  • 10.3.1. Physiological Gynecomastia
  • 10.3.2. Drug-Induced Gynecomastia
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Service Provider
  • 10.4.1. Hospitals & ASCs
  • 10.4.2. Specialty Cosmetic Surgery Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. South Africa
    • 10.5.1.1. By Procedure Type
  • 10.5.2. GCC
    • 10.5.2.1. By Procedure Type
  • 10.5.3. Rest of the Middle East and Africa
    • 10.5.3.1. By Procedure Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. The Plastic Surgery Clinic
  • 11.2.2. Transform Hospital Group
  • 11.2.3. Spire Healthcare Group plc
  • 11.2.4. Nuffield Health
  • 11.2.5. Apollo Cosmetic Clinics
  • 11.2.6. Fortis Healthcare
  • 11.2.7. VLCC Health Care Ltd.
  • 11.2.8. Kaya Limited
  • 11.2.9. Bangkok Hospital Group
  • 11.2.10. Bumrungrad International Hospital